Cell Line Metadata
To download a copy of this information click [MS-Excel] or [text].
|
Cell Name |
Tissue of Origin |
Age |
Sex |
Prior Treatment |
Epithelial |
Histology |
Source |
Ploidy |
|
|
|
Institute |
Contributor |
Reference |
Fingerprint link |
BR:BT_549 |
Breast |
72 |
F |
NA |
yes |
Papillary infiltrating ductal carcinoma-mammary gland; breast |
Metastasis |
3n+/-, Near-triploid 69+/- (58-80) |
? |
-45 |
53.9 |
- |
W. Coutinho; E.Y. Lasfargues |
no pub |
fingerprint |
BR:HS578T |
Breast |
74 |
F |
NA |
yes |
Carcinosarcoma-mammary gland; breast |
Primary |
2n+, Hyperdiploid (47-57) |
MT |
NA |
53.8 |
Naval Bioscience Laboratory |
A.J. Hackett |
JNCI 58: 1795-1806,1977 |
fingerprint |
BR:MCF7 |
Breast |
69 |
F |
NA |
yes |
Adenocarcinoma- mammary gland; breast; metastatic site: pleural effusion; |
Pleural effusion |
3n-, Hypotriploid (58-68) |
WT |
14 |
25.4 |
Michigan Cancer Foundtion |
C.M. McGrath |
JNCI 51: 1409-1417,1973 |
fingerprint |
BR:MDA_MB_231 |
Breast |
51 |
F |
NA |
yes |
Adenocarcinoma-mammary gland; breast; epithelial; metastatic site: pleural effusion; |
Pleural effusion |
2n+, Hyperdiploid (47-57) |
MT |
29 |
41.9 |
MD Anderson Hospital and Tumor Institute |
R. Cailleau |
JNCI 53(3): 661-674,1974 |
fingerprint |
BR:T47D |
Breast |
54 |
F |
NA |
yes |
infiltrating ductal carcinoma |
NA |
2n+, Hyperdiploid (47-57) |
MT |
19 |
45.5 |
- |
I. Keydar |
Eur J Cancer 15:659-679,1979 |
fingerprint |
CNS:SF_268 |
CNS |
24 |
F |
Rad |
no |
Glioblastoma, ud |
NA |
2n+, Hyperdiploid (47-57) |
MT |
-38 |
33.1 |
- |
P.L.Kornblith |
Acta Neuropathol 75: 92-103, 1987 |
fingerprint |
CNS:SF_295 |
CNS |
67 |
F |
Rad |
no |
Glioblastoma, ud |
NA |
5n+/-, Near-pentaploid 115+/- (104-126) |
MT |
91 |
29.5 |
University of California |
M.L. Rosenblum |
Acta Neuropathol 75: 92-103, 1988 |
fingerprint |
CNS:SF_539 |
CNS |
34 |
F |
Rad/BCNU/5FU/HU/6MP |
no |
Glial cell neoplasm |
NA |
4n+/-, Near-tetraploid 92+/- (81-103) |
WT |
-40 |
35.4 |
University of California |
M.L. Rosenblum |
J Neuropathol Exp Neurol 40: 201-229, 1981 |
fingerprint |
CNS:SNB_19 |
CNS |
47 |
M |
None |
no |
Glioblastoma, ud |
NA |
3n+/-, Near-triploid 69+/- (58-80) |
MT |
-41 |
34.6 |
NINCDS |
P.L. Kornblith |
Cancer 47: 255, 1981 |
fingerprint |
CNS:SNB_75 |
CNS |
NA |
F |
None |
no |
Astrocytoma |
NA |
2n+, Hyperdiploid (47-57) |
MT |
-38 |
62.8 |
NINCDS |
P.L. Kornblith |
- |
fingerprint |
CNS:U251 |
CNS |
75 |
M |
NA |
no |
Glioblastoma,ud |
NA |
2n+, Hyperdiploid (47-57) |
MT |
-19 |
23.8 |
University of Uppsala, Sweden |
- |
J Neuropathol Exp Neurol 40: 410-427, 1981 |
fingerprint |
CO:HCT_116 |
Colon |
NA |
M |
NA |
yes |
carcinoma-vpd |
NA |
2n-, Hypodiploid (35-45) |
? |
26 |
17.4 |
Baylor College |
- |
Can Res 41: 1761-1756, 1981 |
fingerprint |
CO:COLO205 |
Colon |
70 |
M |
NA |
yes |
Adenocarcinoma |
Ascites |
3n, Triploid (69) |
MT |
7 |
23.8 |
enver Medical Hospital |
G.E. Moore |
Can Res. 38: 1345-1355, 1978 |
fingerprint |
CO:HCC_2998 |
Colon |
NA |
NA |
NA |
yes |
carcinoma |
NA |
2n+/-, Near-diploid 46+/- (35-57) |
MT |
-5 |
31.5 |
MD Anderson Hospital and Tumor Institute |
- |
- |
fingerprint |
CO:HCT_15 |
Colon |
NA |
NA |
None |
yes |
Adenocarcinoma p/md |
NA |
2n+/-, Near-diploid 46+/- (35-57) |
? |
414 |
20.6 |
ATCC |
ATCC (D.L. Dexter, Roger Williams General Hospital) |
Can Res 39: 1020-1025, 1979 |
fingerprint |
CO:HT29 |
Colon |
44 |
F |
None |
yes |
Adenocarcinoma-md |
Primary |
3n+/-, Near-triploid 69+/- (58-80) |
MT |
15 |
19.5 |
Memorial Sloan Kettering Cancer Center |
J. Fogh |
Human Tumor Cells in vitro: 115-159, 1975 |
fingerprint |
CO:KM12 |
Colon |
NA |
NA |
None |
yes |
Adenocarcinome-pd |
NA |
2n+/-, Near-diploid 46+/- (35-57) |
MT |
-19 |
23.7 |
MD Anderson Hospital and Tumor Institute |
I.J. Fidler, Univ of Texas M.D. Anderson Hospital and Tumor Institute |
Can Res 48: 1943-1948, 1988 |
fingerprint |
CO:SW_620 |
Colon |
51 |
M |
NA |
yes |
Carcinoma-ud |
NA |
2n+/-, Near-diploid 46+/- (35-57) |
MT |
31 |
20.4 |
Scott White Clinic |
A. Leibovitz |
Can Res 1976 Dec;36(12):4562-9 |
fingerprint |
LC:A549 |
Non-Small Cell Lung |
58 |
M |
NA |
yes |
Adenocarcinoma-p/md |
NA |
3n+/-, Near-triploid 69+/- (58-80) |
WT |
10 |
22.9 |
NCI |
Giard DJ |
J Natl Cancer Inst. 51(5):1417-23, 1973 |
fingerprint |
LC:EKVX |
Non-Small Cell Lung |
NA |
M |
NA |
yes |
Adenocarcinoma-md |
NA |
3n+/-, Near-triploid 69+/- (58-80) |
MT |
-9 |
43.6 |
Norsk Hydro's Institut, Norway |
- |
- |
fingerprint |
LC:HOP_62 |
Non-Small Cell Lung |
60 |
F |
None |
yes |
adenocarcinoma-ud |
NA |
4n+, Hypertetraploid (93-103) |
MT |
61 |
39 |
Johns Hopkins University |
M.Liu |
- |
fingerprint |
LC:HOP_92 |
Non-Small Cell Lung |
62 |
M |
None |
yes |
Large cell-ud |
NA |
4n+/-, Near-tetraploid 92+/- (81-103) |
MT |
-4 |
79.5 |
Johns Hopkins University |
M.Liu |
- |
fingerprint |
LC:NCI_H226 |
Non-Small Cell Lung |
NA |
M |
None (non smoker) |
yes |
Squamous cell carcinoma-vpd |
NA |
3n, Triploid (69) |
MT |
7 |
61 |
NCI |
J.D. Minna; A.F. Gazdar |
Cancer Res. 40: 3502-3507, 1980 |
fingerprint |
LC:NCI_H23 |
Non-Small Cell Lung |
NA |
M |
None |
yes |
Adenocarcinoma-ud |
NA |
2n+, Hyperdiploid (47-57) |
MT |
-2 |
33.4 |
NCI |
J.D. Minna; A.F. Gazdar |
Cancer Res. 40: 3502-3507, 1980 |
fingerprint |
LC:NCI_H322M |
Non-Small Cell Lung |
52 |
M |
None |
yes |
Small cell Bronchioalveolar Carcinoma |
NA |
2n+/-, Near-diploid 46+/- (35-57) |
MT |
-10 |
35.3 |
NCI |
- |
- |
fingerprint |
LC:NCI_H460 |
Non-Small Cell Lung |
NA |
M |
NA |
yes |
Large Cell Carcinoma-ud |
Pleural effusion |
2n+/-, Near-diploid 46+/- (35-57) |
WT |
25 |
17.8 |
NCI |
J.D. Minna; A.F. Gazdar |
Science 246: 491-494, 1989 |
fingerprint |
LC:NCI_H522 |
Non-Small Cell Lung |
NA |
M |
None |
yes |
Adenocarcinoma-vpd |
NA |
2n+/-, Near-diploid 46+/- (35-57) |
MT |
16 |
38.2 |
NCI |
- |
Can Res 45: 2913-2923, 1985 |
fingerprint |
LE:CCRF_CEM |
Leukemia |
4 |
F |
Rad/Mtx/Cyx |
no |
ALL |
NA |
2n+/-, Near-diploid 46+/- (35-57) |
MT |
35 |
26.7 |
Children's Cancer research Foudation |
G.E. Foley |
Cancer 18: 522-529, 1965 |
fingerprint |
LE:HL_60 |
Leukemia |
36 |
M |
None |
no |
Pro myelocytic leukemia |
PBL |
2n+/-, Near-diploid 46+/- (35-57) |
MT |
-11 |
28.6 |
NCI |
R.C. Gallo |
Blood 54(3):713-33, 1979 |
fingerprint |
LE:K_562 |
Leukemia |
53 |
F |
Bisulfan/PiBr |
no |
CML |
Pleural effusion |
3n-, Hypotriploid (58-68) |
MT |
-1 |
19.6 |
University of Tennesse |
H.T. Holden |
Blood 45: 321-334, 1975 |
fingerprint |
LE:MOLT_4 |
Leukemia |
19 |
M |
VB/6MP/Pred |
no |
ALL (cells were taken when patient was in relapse) |
PB |
4n, Tetraploid (92) |
WT |
10 |
27.9 |
Roswell Park Memorial Institute |
J. Minowada |
J. Natl. Cancer Inst. 49: 891-895, 1972 |
fingerprint |
LE:RPMI_8226 |
Leukemia |
61 |
M |
None |
no |
Myeloma |
PB |
3n-, Hypotriploid (58-68) |
WT |
-3 |
33.5 |
- |
G.E. Moore |
Proc Soc Exp Biol Med 125: 1246-1250, 1967 |
fingerprint |
LE:SR |
Leukemia |
11 |
M |
Y |
no |
Lymphoma |
NA |
2n+/-, Near-diploid 46+/- (35-57) |
? |
4 |
28.7 |
Program Resources, Inc. |
W.J. Urba, Program Resources, Inc. |
- |
fingerprint |
ME:LOXIMVI |
Melanoma |
58 |
M |
None |
no |
Malignant amelanotic melanoma |
NA |
3n+/-, Near-triploid 69+/- (58-80) |
WT |
12 |
20.5 |
Norsk Hydro's Institut, Norway |
- |
Int J Cancer 41: 442-449, 1988 |
fingerprint |
ME:M14 |
Melanoma |
NA |
NA |
NA |
no |
Melanotic melanoma |
NA |
3n+/-, Near-triploid 69+/- (58-80) |
MT |
14 |
26.3 |
John Wayne Cancer Clinic, UCLA School of Medicine |
D.H. Kern, John Wayne Cancer Clinic, UCLA School of Medicine |
Cancer Res 48: 578-582, 1988 |
fingerprint |
ME:MALME_3M |
Melanoma |
43 |
M |
None |
no |
Malignant melanotic melanoma |
Metastasis |
4n+/-, Near-tetraploid 92+/- (81-103) |
WT |
22 |
46.2 |
Memorial Sloan Kettering Cancer Center |
J. Fogh |
J. Natl. Cancer Inst. 59: 221-226, 1977 |
fingerprint |
ME:MDA_MB_435 |
Melanoma |
31 |
F |
NA |
no |
Ductal carcinoma- mammary gland; breast; duct; metastatic site: pleural effusion; |
Pleural effusion |
2n+, Hyperdiploid (47-57) |
MT |
20 |
25.8 |
- |
R. Cailleau |
Cancer Res 40:3118-3129,1980 |
fingerprint |
ME:MDA_N |
Melanoma |
31 |
F |
NA |
no |
Ductal carcinoma- mammary gland; breast; duct; metastatic site: pleural effusion; |
Pleural effusion |
NA |
MT |
12 |
22.5 |
- |
- |
- |
fingerprint |
ME:SK_MEL_2 |
Melanoma |
60 |
M |
None |
no |
Malignant melanotic melanoma |
Metastasis |
4n-, Hypotetraploid (81-91) |
WT |
14 |
45.5 |
Memorial Sloan Kettering Cancer Center |
G. Trempe; L.J. Old |
Human Tumor Cells in vitro, pp 115-159, 1975 |
fingerprint |
ME:SK_MEL_28 |
Melanoma |
51 |
M |
None |
no |
Malignant melanotic melanoma |
NA |
4n-, Hypotetraploid (81-91) |
MT |
11 |
35.1 |
Memorial Sloan Kettering Cancer Center |
T. Takahashi |
PNAS 73: 3278-3282, 1976 |
fingerprint |
ME:SK_MEL_5 |
Melanoma |
24 |
F |
None |
no |
Malignant melanotic melanoma |
Metastasis |
4n+, Hypertetraploid (93-103) |
WT |
12 |
25.2 |
Memorial Sloan Kettering Cancer Center |
T. Takahashi |
PNAS, 73: 3278-3282, 1976 |
fingerprint |
ME:UACC_257 |
Melanoma |
NA |
NA |
NA |
no |
Melanotic melanoma |
NA |
3n+, Hypertriploid (70-80) |
WT |
26 |
38.5 |
University of Arizona |
A. Leibovitz, UACC |
- |
fingerprint |
ME:UACC_62 |
Melanoma |
NA |
NA |
NA |
no |
Melanotic melanoma |
NA |
3n+/-, Near-triploid 69+/- (58-80) |
WT |
8 |
31.3 |
University of Arizona |
A. Leibovitz, UACC |
- |
fingerprint |
OV:IGROV1 |
Ovarian |
47 |
F |
Rad |
yes |
Cystoadenocarcinoma-pd |
NA |
4n+/-, Near-tetraploid 92+/- (81-103) |
MT |
20 |
31 |
Institute Gustave Roussy, France |
- |
Can Res 45: 4970-4979,1985 |
fingerprint |
OV:OVCAR_3 |
Ovarian |
60 |
F |
CyPh/CsPt/Adr |
yes |
Adenocarcinoma-md |
Ascites |
3n+/-, Near-triploid 69+/- (58-80) |
MT |
-12 |
34.7 |
NCI |
T.C. Hamilton |
Sem Ocol 11: 285-298, 1984 |
fingerprint |
OV:OVCAR_4 |
Ovarian |
42 |
F |
CyPh/CsPt/Adr |
yes |
Adenocarcinoma-md |
NA |
3n+/-, Near-triploid 69+/- (58-80) |
WT |
-4 |
41.4 |
NCI |
T.C. Hamilton |
Sem Ocol 11: 285-298, 1984 |
fingerprint |
OV:OVCAR_5 |
Ovarian |
67 |
F |
None |
yes |
Adenocarcinoma-wd |
NA |
2n+, Hyperdiploid (47-57) |
MT |
13 |
48.8 |
NCI |
R. Ozols |
Sem Ocol 11: 285-298, 1985 |
fingerprint |
OV:OVCAR_8 |
Ovarian |
64 |
F |
Ctx/Adr/CsPt/CyPh |
yes |
Carcinoma-ud |
NA |
2n+, Hyperdiploid (47-57) |
MT |
7 |
26.1 |
NCI |
T.C. Hamilton |
- |
fingerprint |
OV:NCI_ADR_RES |
Ovarian |
NA |
F |
NA |
yes |
Adenocarinoma |
NA |
2n+/-, Near-diploid 46+/- (35-57) |
MT |
352 |
34 |
NCI |
K.Cowan, NCI |
Cancer Res., 46:4087-4090,1986 |
fingerprint |
OV:SK_OV_3 |
Ovarian |
64 |
F |
Thiotepa |
yes |
Adenocarcinoma-vpd |
Ascites |
4n+/-, Near-tetraploid 92+/- (81-103) |
? |
15 |
48.7 |
Memorial Sloan Kettering Cancer Center |
- |
Human Tumor Cells in vitro, pp. 115-159, 1975 |
fingerprint |
PR:DU_145 |
Prostate |
69 |
M |
Androgen independent and unresposive to hormone therapy |
yes |
prostate; metastatic site: brain; carcinoma (patient with metastatic carcinoma of the prostate and a 3 year history of lymphocytic leukemia.) |
Metastasis |
3n+/-, Near-triploid 69+/- (58-80) |
? |
4 |
32.3 |
Washington University School of Medicine, Saint Louis, MO |
K.R. Stone |
Int J Cancer 21: 274-281,1978 |
fingerprint |
PR:PC_3 |
Prostate |
62 |
M |
NA |
yes |
Adenocarcinoma- prostate; metastatic site: bone; |
NA |
4n, Tetraploid (92) |
MT |
11 |
27.1 |
Pasadena Center for Medical Research |
M.E. Kaighn |
Invest Urol 1979 Jul;17(1):16-23 |
fingerprint |
RE:786_0 |
Renal |
58 |
M |
None |
yes |
Adenocarcinoma |
NA |
4n+/-, Near-tetraploid 92+/- (81-103) |
MT |
-44 |
22.4 |
- |
R.D.Williams, Univ. of Iowa |
In Vitro 14: 779-786, 1978 |
fingerprint |
RE:A498 |
Renal |
52 |
F |
NA |
yes |
Adenocarcinoma |
NA |
3n, Triploid (69) |
WT |
78 |
66.8 |
NCI |
- |
JNCI 51: 1417-1423,1973 |
fingerprint |
RE:ACHN |
Renal |
22 |
M |
Rad/VB/CCNU/Mto/Pred |
yes |
Renal cell carcinoma-p/md |
NA |
2n+/-, Near-diploid 46+/- (35-57) |
WT |
120 |
27.5 |
Southern Research Inst. (T.F. Hogan, Middleton memorial VA hospital) |
S.M.Schmid |
Cancer Res 42: 4948-4953, 1982 |
fingerprint |
RE:CAKI_1 |
Renal |
49 |
M |
Rad/HU/5FU/Mtx/Ctx |
yes |
Clear cell carcinoma |
Metastasis |
3n, Triploid (69) |
WT |
171 |
39 |
Memorial Sloan Kettering Cancer Center |
J. Fogh |
Human Tumor cells in vitro, pp 115-159, 1975 |
fingerprint |
RE:RXF_393 |
Renal |
54 |
M |
None |
yes |
hypernephroma-pd |
NA |
3n+/-, Near-triploid 69+/- (58-80) |
MT |
42 |
62.9 |
MD Anderson Hospital and Tumor Institute |
NCI/DCT/DTP |
Contrib oncol 42, 1992 |
fingerprint |
RE:SN12C |
Renal |
43 |
M |
None |
yes |
Renal cell carcinoma-pd |
NA |
3n, Triploid (69) |
MT |
-86 |
29.5 |
MD Anderson Hospital and Tumor Institute |
.J.Fidler |
Cancer Res 46: 4109-4115, 1986 |
fingerprint |
RE:TK_10 |
Renal |
43 |
M |
None |
yes |
Renal Spindle cell carcinoma |
NA |
4n, Tetraploid (92) |
MT |
-4 |
51.3 |
- |
R.V.Clayman, Washington Univ.School of Medicine |
Cancer Res 46: 3856-3862, 1987 |
fingerprint |
RE:UO_31 |
Renal |
NA |
F |
None |
yes |
Renal cell carcinoma-vpd |
NA |
2n+/-, Near-diploid 46+/- (35-57) |
WT |
59 |
41.7 |
NCI |
W.M.Linehan |
- |
fingerprint |